 |
 |
Pfizer cuts Viagra price in Canada after losing patent case
23 November 2012
|
|
|
|
China clears Nestle’s $11.85-bn deal for Pfizer's baby food business
03 November 2012
|
|
|
Pfizer to buy ADHD drug maker NextWave Pharma for $255 mn
22 October 2012
|
| | |
|
|
Pfizer files IPO for animal health unit Zoetis Inc
14 August 2012
|
|
|
Pfizer to pay $60 mn to settle US bribery charges
08 August 2012
|
|
|
Pfizer prepares IPO for its animal healthcare unit
08 June 2012
|
|
|
Nestlé to acquire Pfizer’s nutrition business for $11.85 billion
23 April 2012
|
|
|
Danone raises bid to $11 bn for Pfizer's infant nutrition business
20 April 2012
|
|
|
Nestle close to buying Pfizer’s infant nutrition business for $9 billion
18 April 2012
|
|
|
Pfizer terminates $350-mn insulin marketing deal with Biocon
13 March 2012
|
|
|
Danone, Mead Johnson team up against Nestle for Pfizer's $10-bn infant nutrition
25 February 2012
|
|
|
Pfizer, China’s Zhejiang to form $545 million JV for generic medicines
20 February 2012
|
|
|
Pfizer mulls $3 billion partial IPO for animal healthcare unit: report
20 February 2012
|
|
|
Wyeth Pharma seeks damages of $960 million over Protonix drug patent dispute
16 February 2012
|
|
|
Pfizer recalls 1 million birth-control pills
01 February 2012
|
|
|
Pfizer battles dwindling Lipitor sales with hike in dividend, stock buy-back plan
13 December 2011
|
|
|
Pfizer to buy skin scarring drugmaker Excaliard Pharmaceuticals
23 November 2011
|
|
|
Pfizer to settle bribery charges with US government: report
21 November 2011
|
|
|
Pfizer's global health programme awarded Best International Ambassador award
19 November 2011
|
|
|
US FDA expert committee gives nod to the use of Pfizer’s Prevnar in adults
18 November 2011
|
|
|
Pfizer, Ranbaxy sued over Lipitor price fixing in the US
10 November 2011
|
|
|
Mylan to acquire Pfizer’s generic version of Advair with inhaler technology
10 November 2011
|
|
|
China Mengniu Dairy plans to bid for Pfizer Nutrition: report
24 October 2011
|
|
|
Pfizer plans to sell animal health and nutrition businesses
07 July 2011
|
|
|
Wockhardt's generic version of Pfizer's Effexor XR capsules gets US FDA approval
19 April 2011
|
|
|
Mylan gains 180-day marketing exclusivity on Pfizer's Vfend generics
16 February 2011
|
|
|
Pfizer inks $208 million anti-cancer technology deal with Seattle Genetics
07 January 2011
|
|
|
Dr Reddy’s set to face Pfizer in court over patent suit
06 January 2011
|
|
|
Pfizer moves court against Dr Reddy's launch of atorvastatin in US market
04 January 2011
|
|
|
Pfizer Animal Health to acquire veterinary diagnostics firm Synbiotics Corp
30 December 2010
|
|
|
WikiLeaks: Pfizer derailed investigations over clandestine drug trials in Nigeria
11 December 2010
|
|
|
Pfizer buys 40-% stake in Brazilian generics firm Teuto for $240 million
20 October 2010
|
|
|
Pfizer, Biocon enter into deal for biosimilar insulin
19 October 2010
|
|
|
Pfizer to buy pain drug company King Pharma for $3.6 billion
12 October 2010
|
|
|
Pfizer to acquire FoldRx Pharmaceuticalsing
01 September 2010
|
|
|
Conatus Pharmaceuticals buys Pfizer's Idun subsidiary
31 July 2010
|
|
|
Pfizer to close eight plants, shed 6,000 jobs worldwide
18 May 2010
|
|
|
Cipla in talks for supply of drugs to Pfizer: Reports
08 May 2010
|
|
|
Sigma-Aldrich to sell Pfizer's bioactive small molecule compounds
15 March 2010
|
|
|
Eli Lilly’s Elanco takes over Pfizer’s European animal health portfolio
09 March 2010
|
|
|
Pfizer in bid to snap up Germany’s Ratiopharm
04 March 2010
|
|
|
Pfizer to market 40 Strides Arcolab generic drugs in the US
07 January 2010
|
|
|
Pfizer acquires the rights to a stem-cell drug from Athersys
21 December 2009
|
|
|
Pfizer inks $115 million deal with Israel’s Protalix for treatment of Gaucher’s disease
02 December 2009
|
|
|
Pfizer to slash R&D facilities post Wyeth merger
11 November 2009
|
|
|
Pfizer unit fined record $1.3 billion for drug misbranding
19 October 2009
|
|
|
Pfizer completes Wyeth acquisition
16 October 2009
|
|
|
FDA advisory committee recommends approval of Pfizer’s Selzentry for HIV
09 October 2009
|
|
|
Pfizer, Wyeth to sell animal drugs business to Boehringer
23 September 2009
|
|
|
Pfizer agrees to pay $2.3 billion to settle illegal marketing case
03 September 2009
|
|
|
Pfizer and Astellas in co-promotion pact for Caduet combination medication in Japan
26 August 2009
|
|
|
Pfizer, Mylan lower HIV drug prices for drug-resistant patients
08 August 2009
|
|
|
Pfizer settles Trovan cases; pays $75 million to Nigerian state
31 July 2009
|
|
|
EC approves Pfizer's $68-billion acquisition of Wyeth
18 July 2009
|
|
|
Pfizer sweetens bid for India arm to Rs830 per share
25 June 2009
|
|
|
Pfizer to expand presence in generic drugs marketing
21 May 2009
|
|
|
Pfizer brings patent infringement suits against Sun, Lupin, Wockhardt
06 May 2009
|
|
|
GSK, Pfizer to merge HIV businesses into a new company
17 April 2009
|
|
|
Pfizer seeks to increase stake in Indian arm
13 April 2009
|
|
|
Pfizer raises $13.5-billion debt to part finance Wyeth acquisition
18 March 2009
|
|
|
Pfizer sells insulin assets to Anti-diabetes drugmaker MannKind for $33 million
09 March 2009
|
|
|
Pfizer ties up with Aurobindo for generic drugs
04 March 2009
|
|
|
Pfizer acquires rights to several generics from Aurobindo
03 March 2009
|
|
|
Pfizer discontinues global phase III trial of Axitinib for futility in advanced pancreatic cancer
31 January 2009
|
|
|
Pfizer-Wyeth create $68-billion blockbuster deal
27 January 2009
|
|
|
Pfizer in talks to acquire Wyeth for $60 billion
23 January 2009
|
|
|
New job cuts at Jaguar, Pfizer, Barclays put doubts on £500-million job rescue plan
15 January 2009
|
|
|
Pfizer ends testing obesity drug on account of risk of US non-approval
06 November 2008
|
|
|
Pfizer reaches $894 million settlement to resolve Bextra litigation
18 October 2008
|
|
|
Pfizer to settle Lipitor case with Canada's Apotex
11 August 2008
|
|
|
Ranbaxy banks on Pfizer settlement to revive falling fortunes
29 July 2008
|
|
|
CNBC-TV18 shares with domain-b its exclusive interview with Malvinder Singh
18 June 2008
|
|
|
Pfizer and Ranbaxy settle global Lipitor patent litigation
18 June 2008
|
|
|
Divested from Pfizer, Esperion Therapeutics completes $22.75-million series A financing
03 May 2008
|
|
|
Ranbaxy gets a boost as US patent office rejects Pfizer's Liptor plea
28 April 2008
|
|
|
Pfizer forms diabetes, obesity research consortium with universities
26 April 2008
|
|
|
Pfizer Animal Health to acquire Catapult Genetics and Bovigen
19 March 2008
|
|
|
Pfizer to acquire Serenex, extend oncology pipeline
05 March 2008
|
|
|
Pfizer-funded study reports reduction in heart attacks by adding Lipitor early to blood pressure treatment
18 January 2008
|
|
|
Pfizer to outsource 30 per cent of manufacturing to Asia, cut 10,000 jobs
04 December 2007
|
|
|
Pfizer to acquire Coley Pharmaceutical for $164 million
19 November 2007
|
|
|
Pfizer
to license Taisho Pharmaceutical''s schizophrenia drug candidate TS-032
01 November 2007
|
|
|
Hearing
on Pfizer''s Nigeria drug trial to resume on 3 October
01 October 2007
|
|
|
Pfizer
and Bristol-Myers Squibb to collaborate globally on metabolic disorders
28 August 2007
|
|
|
Ranbaxy
could gain as Pfizer loses initial bid for Lipitor patent extension
17 August 2007
|
|
|
Nigeria
sues Pfizer for illegal drug trials, claims $7 billion
in damages
05 June 2007
|
|
|
Pfizer loses battle for Chinese name for Viagra
06 February 2007
|
|
|
Pfizer wins Norvasc patent case against Synthon
02 February 2007
|
|
|
Pfizer to retrench 8,000
22 January 2007
|
|
|
Pfizer aborts cholesterol drug tests
04 December 2006
|
|
|
Mixed victory for Ranbaxy in patent row with Pfizer
03 August 2006
|
|
|
J&J to acquire Pfizer Consumer Healthcare for $16.6 billion
26 June 2006
|
|
|
Pfizer India Q1 net jumps 84 per cent
29 March 2006
|
|
|
Pfizer FY05 net rises 50 per cent despite weak Q4
27 February 2006
|
|
|
Ranbaxy scores over Pfizer in Norwegian court over cholesterol drug
10 November 2005
|
|
|
On the clinical trial trail
11 March 2005
|
|
|
Pfizer
recalls liquid Gelusil
28 February 2004
|
|
|
Pfizer
India plans to put three manufacturing units on block
22 December 2003
|
|
|
SC
order to expedite pending merger of Pharmacia with Pfizer
22 September 2003
|
|
|
Novo Nordisk ignores IPR, to launch new products in India
13 December 2002
|
|
|
Pfizer
sells Protinex for $ 7 million
29 November 2002
|
|
|
Pfizer restructures R&D
20 November 2000
|
|
|
Merger impact in India
07 February 2000
|
|
|
Top ranking brands of Pfizer and Parke Davis
07 February 2000
|
|
|
Competitive advantages of Pfizer-Warner Lambert combine
07 February 2000
|
|
|
Pfizer acquires Warner Lambert
07 February 2000
|
|
|
Pfizer, Parke Davis - top therapeutic classes
07 February 2000
|
|
|
Pfizer''s new Becosules Plus will beat price control
17 August 1999
|
